AN LAM: Open Payments
NPI 1457826067 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 46 payments from 17 companies in 2025. Trend: 2023 $948 · 2024 $1,608 · 2025 $1,150
Food & beverage: $1,149Education: $2
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $139 |
| AstraZeneca Pharmaceuticals LP | 6 | $118 |
| Fresenius USA Marketing, Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Vifor Pharma, Inc. | 3 | $84 |
| Amgen Inc. | 4 | $81 |
| NxStage Medical, Inc. | 1 | $66 |
| ANI Pharmaceuticals, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $49 |
Products named: Vanrafia, TERLIVAZ, VELPHORO, JYNARQUE, FARXIGA, Veltassa, TAVNEOS, NXSTAGE SYSTEM ONE.
Industry payments across MS — which companies pay providers there.
